Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,730 | 60,565 | 6,813 | 5,701 | 16,344 |
| Receivables | 10,247 | 12,339 | 14,856 | 15,409 | 8,056 |
| Inventories | 7,148 | 5,950 | 8,153 | 9,280 | 11,468 |
| TOTAL | $64,904 | $80,988 | $31,740 | $31,510 | $37,483 |
| Non-Current Assets | |||||
| PPE Net | 28,364 | 28,594 | 29,855 | 31,719 | 35,553 |
| Investments And Advances | 0 | 0 | 0 | 0 | 905 |
| Intangibles | 14,373 | 14,570 | 14,808 | 15,278 | 124,397 |
| Other Non-Current Assets | 30,531 | 29,690 | 29,399 | 875 | 5,132 |
| TOTAL | $73,268 | $72,854 | $74,062 | $47,872 | $165,986 |
| Total Assets | $138,173 | $153,842 | $105,802 | $79,381 | $203,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 309 | 423 | 2,504 | 2,477 | 1,637 |
| Accounts payable and accrued liabilities | 15,104 | 12,673 | 22,100 | 24,576 | 22,373 |
| Other current liabilities | N/A | N/A | 1,145 | 121 | N/A |
| TOTAL | $22,527 | $19,944 | $33,353 | $27,566 | $24,628 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,525 | 6,400 | 107,512 | 94,581 | 115,226 |
| Deferred Revenues | 279 | 400 | 388 | 391 | 617 |
| Other Non-Current Liabilities | 2,621 | 2,662 | 3,347 | 33,931 | 3,639 |
| TOTAL | $34,819 | $33,475 | $135,688 | $100,533 | $129,867 |
| Total Liabilities | $57,346 | $53,419 | $169,041 | $128,098 | $154,495 |
| Shareholders' Equity | |||||
| Common Shares | 706,804 | 697,567 | 443,558 | 449,875 | 445,342 |
| Retained earnings | -721,716 | -690,081 | -589,878 | -583,013 | -498,973 |
| Other shareholders' equity | 65,009 | 64,576 | 65,436 | 67,508 | 88,287 |
| TOTAL | $80,827 | $100,424 | $-63,239 | $-48,717 | $48,975 |
| Total Liabilities And Equity | $138,173 | $153,842 | $105,802 | $79,381 | $203,469 |